BCI LifeSciences is an advisory firm, comprised of distinguished Senior Level executives from the Life Sciences industry.
Our executives and advisors have been Founders, Chairmen, Presidents, CEOs and COOs of large multinational organizations and emerging healthcare companies in the United States and abroad.
Our team members have advanced operating and transaction experience in biotechnology, pharmaceuticals, medical devices and clinical diagnostics.
We are experienced at every stage of the growth process, including business analysis, communications, government and agency interface, licensing, in-house and outsourced manufacturing, vendor optimization, distribution, regulatory compliance and global network development.
BCI LifeSciences has extensive experience advising companies and management teams in the life sciences industry from start-ups to multinationals, worldwide.
In addition to our deep bench of life science skills and know-how, our clients benefit from the broad expertise of our platform partners: Bankers Capital International and BCI Advisors Inc. Bankers Capital International, is our investment banking arm, focused on institutional capital, private placements, IPO’s, mergers and acquisitions and business combinations of numerous types worldwide. BCI Advisors Inc is our public-company qualifications and listing arm, focused on clients wishing to go public through an IPO, undergo a SPAC-merger, reverse merge into a public company, cross-list, up-list and/or go private.
The value proposition of BCI LifeSciences is both its skills and its platform: clients can access significant industry-specific expertise for growth planning; leverage comprehensive skills and experience in choosing to enter and operate in the public-company markets; and, through Bankers Capital International, build wealth through capital formation, mergers and acquisitions and other liquidity events – all on a seamless and unified platform.